Rankings
▼
Calendar
OMER
Omeros Corporation
$846M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
Gross Profit
$11M
96.7% margin
Operating Income
-$12M
-106.6% margin
Net Income
-$14M
-123.7% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
+12.8%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$73M
Total Liabilities
$96M
Stockholders' Equity
-$23M
Cash & Equivalents
$10M
← FY 2016
All Quarters
Q4 2016 →
OMER Q3 2016 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena